Picture of Avalo Therapeutics logo

AVTX — Avalo Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Brief: Avalo Therapeutics Announces Pricing Of $375 Million Public Offering At $17.75 Per Share

May 5 (Reuters) - Avalo Therapeutics Inc AVTX.O:

AVALO THERAPEUTICS ANNOUNCES PRICING OF $375 MILLION PUBLIC OFFERING

AVALO THERAPEUTICS INC - SHARES SOLD AT $17.75 PER SHARE

Source text: ID:nGNX949n29

Further company coverage: AVTX.O

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Avalo Therapeutics

See all news